1. Home
  2. LSAK vs ABSI Comparison

LSAK vs ABSI Comparison

Compare LSAK & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSAK
  • ABSI
  • Stock Information
  • Founded
  • LSAK 1997
  • ABSI 2011
  • Country
  • LSAK South Africa
  • ABSI United States
  • Employees
  • LSAK N/A
  • ABSI N/A
  • Industry
  • LSAK Investment Bankers/Brokers/Service
  • ABSI Biotechnology: Pharmaceutical Preparations
  • Sector
  • LSAK Finance
  • ABSI Health Care
  • Exchange
  • LSAK Nasdaq
  • ABSI Nasdaq
  • Market Cap
  • LSAK 344.5M
  • ABSI 338.0M
  • IPO Year
  • LSAK N/A
  • ABSI 2021
  • Fundamental
  • Price
  • LSAK $4.74
  • ABSI $2.39
  • Analyst Decision
  • LSAK
  • ABSI Strong Buy
  • Analyst Count
  • LSAK 0
  • ABSI 5
  • Target Price
  • LSAK N/A
  • ABSI $7.98
  • AVG Volume (30 Days)
  • LSAK 18.6K
  • ABSI 4.4M
  • Earning Date
  • LSAK 09-10-2025
  • ABSI 08-12-2025
  • Dividend Yield
  • LSAK N/A
  • ABSI N/A
  • EPS Growth
  • LSAK N/A
  • ABSI N/A
  • EPS
  • LSAK N/A
  • ABSI N/A
  • Revenue
  • LSAK $574,080,000.00
  • ABSI $4,138,000.00
  • Revenue This Year
  • LSAK $1.06
  • ABSI $44.71
  • Revenue Next Year
  • LSAK $13.32
  • ABSI $374.26
  • P/E Ratio
  • LSAK N/A
  • ABSI N/A
  • Revenue Growth
  • LSAK 4.13
  • ABSI 27.32
  • 52 Week Low
  • LSAK $3.39
  • ABSI $2.01
  • 52 Week High
  • LSAK $5.60
  • ABSI $6.33
  • Technical
  • Relative Strength Index (RSI)
  • LSAK 51.59
  • ABSI 33.33
  • Support Level
  • LSAK $4.60
  • ABSI $2.50
  • Resistance Level
  • LSAK $4.76
  • ABSI $2.73
  • Average True Range (ATR)
  • LSAK 0.11
  • ABSI 0.18
  • MACD
  • LSAK -0.01
  • ABSI -0.04
  • Stochastic Oscillator
  • LSAK 36.73
  • ABSI 1.94

About LSAK Lesaka Technologies Inc.

Lesaka Technologies Inc provides payment solutions, transaction processing solutions, and financial technologies. The company operates two reportable segments: Merchant and Consumer. The company operates mainly within South Africa. The Merchant segment that derives majority revenue includes activities related to the provision of goods and services provided to corporate and other juristic entities. It earns fees from processing activities performed for its customers and revenue generated from the distribution of prepaid airtime. The Consumer segment includes activities related to the provision of financial services to customers, including bank accounts, loans, and insurance products. The firm charges monthly administration fees for all bank accounts.

About ABSI Absci Corporation

Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.

Share on Social Networks: